Showing results (621-630 of 1,120) with videos related to
Sort By:
Pageof 112
Circulation|November 15, 2013
High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialZiad Hijazi, Agneta Siegbahn, Ulrika Andersson, et al.Journal of the American Heart Association|September 16, 2017
Sex Differences in Clinical Characteristics, Psychosocial Factors, and Outcomes Among Patients With Stable Coronary Heart Disease: Insights from the STABILITY (Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy) TrialPatricia Oliveira Guimarães, Christopher B Granger, Amanda Stebbins, et al.American Heart Journal|March 8, 2017
Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trialB Daan Westenbrink, Marco Alings, Christopher B Granger, et al.Cell Reports. Medicine|July 1, 2021
Differential modulation of polyunsaturated fatty acids in patients with myocardial infarction treated with ticagrelor or clopidogrelKarla N Samman, Pamela Mehanna, Emad Takla, et al.Journal of the American College of Cardiology|October 27, 2022
Biomarker-Based Prediction of Recurrent Ischemic Events in Patients With Acute Coronary SyndromesGorav Batra, Johan Lindbäck, Richard C Becker, et al.European Journal of Medicinal Chemistry|January 29, 2014
7-Chloroquinolinotriazoles: synthesis by the azide-alkyne cycloaddition click chemistry, antimalarial activity, cytotoxicity and SAR studiesGuilherme R Pereira, Geraldo Célio Brandão, Lucas M Arantes, et al.The American Journal of Medicine|June 14, 2024
Antithrombotic Strategies According to Age: Insights from the AUGUSTUS TrialPatricia O Guimarães, Renato D Lopes, Daniel M Wojdyla, et al.The Lancet. Diabetes & Endocrinology|August 23, 2021
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trialsNaveed Sattar, Matthew M Y Lee, Søren L Kristensen, et al.Journal of the American College of Cardiology|July 6, 2019
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: JACC State-of-the-Art ReviewDavide Capodanno, Kurt Huber, Roxana Mehran, et al.Journal of Thrombosis and Thrombolysis|April 12, 2019
International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarinPatricia O Guimarães, Renato D Lopes, John H Alexander, et al.Pageof 112